Document is current
Any future updates will be listed below
-
Authors
Asher, Nethanel
Raphael, Ari
Wolf, Ido
Pelles, Sharon
Geva, Ravit http://orcid.org/0000-0002-5380-4948
- License Information
-
More Information
Article History
Received: 2 May 2021
Accepted: 28 November 2021
First Online: 7 January 2022
Declarations
:
: The study was approved by the Tel Aviv Sourasky Medical Center ethics committee (0565-14-TLV January 7<sup>th</sup>, 2015).The local IRB approved for this trial the use of the questionnaires and combining informed consent process together. By fulfilling them, the patient agree to participate in this trial. At the header of the questionnaire there is declaration describing the trial and explaining that if they agree to fulfil the questionnaire their answers will be included in the data analysis.
: Not Applicable
: NA: no conflict of interest. AR: no conflict of interest. IW: Honoraria: BMS; Lectures/Research grant: Novartis, BMS, Roche; Consulting and Advisory: Roche. SP: no conflict of interest. RG: Options: BOL Pharma; Honoraria: MSD, Novartis, BMS, Roche, Janssen, Medison, Lilly, Bayer, Pfizer; Consulting and Advisory: BOL Pharma, MSD, Bayer, Novartis, Boehringer Ingelheim; Travel, Accommodations, Expenses: Bayer, Merck, Medison, BMS.
